ys 64 has been researched along with 3-hydroxystigmast-5-en-7-one in 1 studies
| Studies (ys 64) | Trials (ys 64) | Recent Studies (post-2010) (ys 64) | Studies (3-hydroxystigmast-5-en-7-one) | Trials (3-hydroxystigmast-5-en-7-one) | Recent Studies (post-2010) (3-hydroxystigmast-5-en-7-one) |
|---|---|---|---|---|---|
| 7 | 0 | 5 | 7 | 0 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carvalho, JF; Moreira, JN; Sá e Melo, ML; Silva, MM; Simões, S | 1 |
1 other study(ies) available for ys 64 and 3-hydroxystigmast-5-en-7-one
| Article | Year |
|---|---|
Sterols as anticancer agents: synthesis of ring-B oxygenated steroids, cytotoxic profile, and comprehensive SAR analysis.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Cell Line, Tumor; Cell Proliferation; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Sterols; Structure-Activity Relationship | 2010 |